Question 1

What are the most cited papers from AlmavivA (Italy)?

Accepted Answer

The most cited paper from AlmavivA (Italy) is "Neoantigen cancer vaccine augments anti-CTLA-4 efficacy" (Erika Salvatori, Lucia Lione, Mirco Compagnone et al., 2022), with 53 citations. Next come "Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth" (44) and "Overexpression of HER ‐2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma ‐ A marker of malignancy and possible therapeutic target" (33).

Question 2

Which research topics does AlmavivA (Italy) publish most on?

Accepted Answer

By volume in 2022-now: Remote Sensing and LiDAR Applications, CAR-T cell therapy research, Immunotherapy and Immune Responses and Remote-Sensing Image Classification.

Question 3

Which fields of science does AlmavivA (Italy) work in?

Accepted Answer

In all years, 57% of research at AlmavivA (Italy) is in Physical Sciences, 23% in Social Sciences. Its largest fields are Computer Science (27%), Social Sciences (15%), Engineering (13%). It does 1.3× the world's share of Physical Sciences.

Question 4

Is AlmavivA (Italy)'s research output growing?

Accepted Answer

Output in 2022-2025 was 196% higher than in 2018-2021.